BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3873985)

  • 1. Control of primary osteosarcoma with chemotherapy.
    Jaffe N; Robertson R; Takaue Y; Cangir A; Wallace S; Carrasco H; Eftekhari F; Ayala A; Wang A
    Cancer; 1985 Aug; 56(3):461-6. PubMed ID: 3873985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.
    Jaffe N; Robertson R; Ayala A; Wallace S; Chuang V; Anzai T; Cangir A; Wang YM; Chen T
    J Clin Oncol; 1985 Aug; 3(8):1101-4. PubMed ID: 3874932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric osteosarcoma. Successful retreatment of relapsed primary tumor and soft tissue recurrence with intraarterial cis-diamminedichloroplatin-II.
    Epelman S; Estrada J; Jaffe N; Bianchi A
    Cancer; 1990 Aug; 66(4):801-5. PubMed ID: 2386906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.
    Jaffe N; Spears R; Eftekhari F; Robertson R; Cangir A; Takaue Y; Carrasco H; Wallace S; Ayala A; Raymond K
    Cancer; 1987 Feb; 59(4):701-9. PubMed ID: 3492261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
    Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
    Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative intra-arterial chemotherapy in patients with osteosarcoma: case report of seven patients below the age of 18 years.
    Barjaktarević Z; Sbutega B; Bekić Z; Munjas N; Atanacković M
    J Chemother; 1990 Oct; 2(5):331-5. PubMed ID: 1708815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
    Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
    Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chemotherapy combined with caffeine for osteosarcoma.
    Tsuchiya H; Yasutake H; Yokogawa A; Baba H; Ueda Y; Tomita K
    J Cancer Res Clin Oncol; 1992; 118(8):567-9. PubMed ID: 1517277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
    Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
    Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate.
    Jaffe N; Prudich J; Knapp J; Wang YM; Bowman R; Cangir A; Ayala A; Chuang V; Wallace S
    J Clin Oncol; 1983 Jul; 1(7):428-31. PubMed ID: 6607977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.
    Bacci G; Gherlinzoni F; Picci P; Van Horn JR; Jaffe N; Guerra A; Ruggieri P; Biagini R; Capanna R; Toni A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1337-45. PubMed ID: 3493903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
    Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
    J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues.
    Jaffe N
    Cancer Treat Res; 1993; 62():75-84. PubMed ID: 8096762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
    Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.